Erythromycin-benzoyl Peroxide
Pricing Report NDC 45802-083-86

Latest NADAC: $4.98334 per GM · Effective Dec 21, 2016
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Erythromycin-benzoyl Peroxide (NDC 45802-083-86) is $4.98334 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Dec 21, 2016.

As a provided by Perrigo New York Inc, this medication is distributed in a 1 KIT in 1 BOX * 1.6 g in 1 VIAL, PLASTIC * 40 g in 1 JAR configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$4.98334
Per GM

Pricing Unit
Per GM Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Dec 21, 2016
Data Status
As of Dec 28, 2016
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
45802-083-86
Description
1 KIT in 1 BOX * 1.6 g in 1 VIAL, PLASTIC * 40 g in 1 JAR
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.69681 to $6.65199 per GM. Over this 3 years and 1 month period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.9517 - $6.6520
Market Volatility
599.00% Variance
Latest Trend
7.57%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Dec 21, 2016 $5.51507 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 21, 2016 $4.98334 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 23, 2016 $5.96652 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 23, 2016 $4.94782 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 19, 2016 $5.94840 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 19, 2016 $5.31572 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 21, 2016 $5.77793 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 21, 2016 $5.40127 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 17, 2016 $5.83358 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 17, 2016 $6.05541 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 20, 2016 $6.48188 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 20, 2016 $5.76250 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026